Skip to main content
logo
Indoco Remedies Limited (NSE:INDOCO)
India flag India · Delayed Price · Currency is INR
210.36
-5.35 (-2.48%)
Jan 23, 2026, 3:29 PM IST

Indoco Remedies Revenue

Indoco Remedies had revenue of 4.85B INR in the quarter ending September 30, 2025, with 12.02% growth. This brings the company's revenue in the last twelve months to 17.25B, down -2.71% year-over-year. In the fiscal year ending March 31, 2025, Indoco Remedies had annual revenue of 16.65B, down -8.38%.

Revenue (ttm)
17.25B
Revenue Growth
-2.71%
P/S Ratio
1.12
Revenue / Employee
2.88M
Employees
6,000
Market Cap
19.41B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202516.65B-1.52B-8.38%
Mar 31, 202418.17B1.49B8.91%
Mar 31, 202316.69B1.28B8.30%
Mar 31, 202215.41B2.99B24.10%
Mar 31, 202112.42B1.35B12.19%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Innova Captab13.63B
Solara Active Pharma Sciences12.06B
Windlas Biotech8.30B
Orchid Pharma8.21B
RPG Life Sciences6.66B
Ind-Swift Laboratories5.72B
Sigachi Industries5.09B
Beta Drugs3.86B
Revenue Rankings

Indoco Remedies News

More News